Accéder au contenu
Merck
  • A novel small molecule facilitates the reprogramming of human somatic cells into a pluripotent state and supports the maintenance of an undifferentiated state of human pluripotent stem cells.

A novel small molecule facilitates the reprogramming of human somatic cells into a pluripotent state and supports the maintenance of an undifferentiated state of human pluripotent stem cells.

Angewandte Chemie (International ed. in English) (2012-11-06)
Jungwoon Lee, Yan Xia, Mi-Young Son, Guanghai Jin, Binna Seol, Min-Jeong Kim, Myung Jin Son, Misol Do, Minho Lee, Dongsup Kim, Kyeong Lee, Yee Sook Cho
RÉSUMÉ

Booster of pluripotency: RSC133, a new synthetic derivative of indoleacrylic acid/indolepropionic acid, exhibits dual activity by inhibiting histone deacetylase and DNA methyltransferase. Furthermore it potently improves the reprogramming of human somatic cells into a pluripotent state and aids the growth and maintenance of human pluripotent stem cells (hPSCs).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Acide indole-3-propionique, ≥99.0% (T)
Sigma-Aldrich
3-Indolepropionic acid, ReagentPlus®, 99%
Sigma-Aldrich
Acide indole-3-propionique, ≥97.0% (T)
Sigma-Aldrich
3-Indoleacrylic acid, ≥98% (HPLC), BioReagent
Sigma-Aldrich
trans-3-Indoleacrylic acid, 98%
Sigma-Aldrich
3-Indoleacrylic acid, powder
Sigma-Aldrich
RSC133, ≥98% (HPLC)